TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02149823

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“All study proceedings stopped prematurely due to Covid-19 restrictions for intranasal formulations”

The sponsor’s own words in the registry.

Life of this trial

20132014201520162017201820192020202120222023Started2013-09Registered2014-05-21Primary completion2020-07Stopped2022-06-14

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
Maria de las Mercedes Perez Rodriguez
Sponsor type
University, hospital or other
Conditions
Borderline Personality Disorder; BPD; Schizotypal Personality Disorder; SPD; Autism Spectrum Disorder; Schizophrenia
Interventions
Syntocinon 24 Intranasal Units (IU); Syntocinon 40 Intranasal Units (IU); Intranasal Placebo
Participants
92
Sites
2
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.